HASHEM EL-SERAG to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Diabetes Mellitus, Type 2.
Connection Strength
0.570
-
Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes. Am J Gastroenterol. 2009 May; 104(5):1241-8.
Score: 0.143
-
The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006 Mar; 4(3):369-80.
Score: 0.116
-
Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System. Dig Dis Sci. 2023 09; 68(9):3634-3643.
Score: 0.096
-
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. Nat Rev Gastroenterol Hepatol. 2022 10; 19(10):638-651.
Score: 0.089
-
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease. Hepatology. 2022 06; 75(6):1420-1428.
Score: 0.086
-
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Intern Med. 2024 Nov 01; 184(11):1314-1323.
Score: 0.026
-
The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther. 2014 Mar; 39(5):518-31.
Score: 0.012